Press releases
- Dexcom Schedules Second Quarter 2024 Earnings Release and Conference Call for July 25, 2024 at 4:30 p.m. Eastern Time.
- Dexcom Expands AID Partnership Into The Netherlands
- Dexcom Showcases Extensive Clinical Data at ADA 2024 Demonstrating the Benefit of Dexcom CGM Use Among People With Type 2 Diabetes
- Dexcom G7 Now Connects Directly to Apple Watch in the U.S.
- Dexcom Wins Access to Dexcom ONE for 100,000 People Living With Type 2 Diabetes
- Nova Scotia Now Providing Coverage for Dexcom Continuous Glucose Monitoring Systems
- Dexcom Announces Upcoming Conference Presentation
- Tandem Mobi Insulin Pump Now Compatible with Dexcom G7 CGM
- Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes
- Dexcom Reports First Quarter 2024 Financial Results
More ▼
Key statistics
As of last trade, Dexcom Inc (DC4X:GER) traded at 101.60, 42.16% above the 52 week low of 71.47 set on Oct 13, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 102.26 |
---|---|
High | 102.26 |
Low | 101.60 |
Bid | 102.56 |
Offer | 103.90 |
Previous close | 101.60 |
Average volume | 36.29 |
---|---|
Shares outstanding | 397.68m |
Free float | 396.46m |
P/E (TTM) | 75.54 |
Market cap | 45.58bn USD |
EPS (TTM) | 1.52 USD |
Data delayed at least 15 minutes, as of Jul 19 2024 16:35 BST.
More ▼